MENU
XERS
AS OF
Dec 24 closing price
Price
$7.21
Change
-$0.07 (-0.96%)
Capitalization
1.2B
76 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
XERS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Xeris Biopharma Holdings (XERS) Ownership - Who owns Xeris Biopharma Holdings?

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
1375 West Fulton Street
Phone
+1 844 445-5704
Employees
377
Web
https://www.xerispharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.2B
P/E Ratio
N/A
Total Cash
91.6M
Projected Growth
N/A
Total Debt
257.65M
Revenue
266.14M
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash/Share
0.55
Total Debt/Equity
N/A
Revenue/Share
1.70 USD as % of share price

Fundamentals

XERS
Capitalization
1.2B
P/E Ratio
N/A
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash
91.6M
Total Cash/Share
0.55
Total Debt
258M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.70%
Revenue
266M
ROE
N/A
Book Value
-861K
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17K
Current Ratio
1.93
Current Revenue Per Employee
188781.72
Dividends Per Share - Security
N/A
EBITDA
26.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
85.22
Revenue To Assets
-4.52
Shares Held By Institutions
1.06B
Shares Outstanding - Current
166M
Total Liabilities
371M
Total Volume MTD
N/A
Value
-1
Gain YTD
114.749
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
XERS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. XERS showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for XERS
A.I. Advisor
published General Information

General Information

a developer of ready-to-use, liquid-stable injectables

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1375 West Fulton Street
Phone
+1 844 445-5704
Employees
377
Web
https://www.xerispharma.com